Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0V6XW
|
|||
| Former ID |
DNCL002246
|
|||
| Drug Name |
Teglarinad
|
|||
| Synonyms |
Teglarinad; UNII-NUG9P5GWZB; 766501-75-1; NUG9P5GWZB; Pyridinium,4-[[[[6-(4-chlorophenoxy)hexyl]imino](cyanoamino)methyl]amino]-1-(3-oxo-2,4,7,10,13,16-hexaoxaheptadec-1-yl)-; Teglarinad [WHO-DD]; SCHEMBL17074712; CHEMBL1181731; ZINC3961863; PyridiniuM, 4-[[[[6-(4-chlorophenoxy)hexyl]iMino](cyanoaMino)Methyl]aMino]-1-(3-oxo-2,4,7,10,13,16-hexaoxaheptadec-1-yl)-; 4-((N'-(6-(4-Chlorophenoxy)hexyl))-N''-cyanocarbamimidamido)-1-(3-oxo-2,4,7,10,13,16-hexaoxaheptadecyl)pyridin-1-ium
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Lymphoma [ICD-11: 2A80-2A86; ICD-9: 202.8, 208.9] | Phase 1 | [1] | |
| Company |
Cephalon
|
|||
| Structure |
 |
Download2D MOL
|
||
| Formula |
C30H43ClN5O8+
|
|||
| Canonical SMILES |
COCCOCCOCCOCCOC(=O)OC[N+]1=CC=C(C=C1)NC(=NCCCCCCOC2=CC=C(C=C2)Cl)NC#N
|
|||
| InChI |
1S/C30H42ClN5O8/c1-38-16-17-39-18-19-40-20-21-41-22-23-43-30(37)44-25-36-13-10-27(11-14-36)35-29(34-24-32)33-12-4-2-3-5-15-42-28-8-6-26(31)7-9-28/h6-11,13-14H,2-5,12,15-23,25H2,1H3,(H,33,34)/p+1
|
|||
| InChIKey |
RXXJCNMVVRGOJB-UHFFFAOYSA-O
|
|||
| CAS Number |
CAS 766501-75-1
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800026283) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.